OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Clinical trials for OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT trials appear
Sign up with your email to follow new studies for OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New obesity pill shows promise in body fat reduction trial
Disease control OngoingThis study tests a new drug called aleniglipron (GSBR-1290) in 71 adults with obesity (BMI 30 or higher). Participants take the drug or a placebo daily for 40 weeks. The main goal is to see how much total body fat changes, measured by a special X-ray scan.
Matched conditions: OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New daily pill shows promise for weight loss in major trial
Disease control OngoingThis study tests an experimental daily pill, aleniglipron, to help people with obesity or overweight lose weight. About 220 adults will receive either the drug or a placebo for 36 weeks, followed by an optional 36-week extension where everyone gets the drug. The goal is to see ho…
Matched conditions: OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated May 05, 2026 11:53 UTC